[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SI2247558T2 - Nova kontrastna sredstva za zaznavanje nevroloških disfunkcij - Google Patents

Nova kontrastna sredstva za zaznavanje nevroloških disfunkcij

Info

Publication number
SI2247558T2
SI2247558T2 SI200932157T SI200932157T SI2247558T2 SI 2247558 T2 SI2247558 T2 SI 2247558T2 SI 200932157 T SI200932157 T SI 200932157T SI 200932157 T SI200932157 T SI 200932157T SI 2247558 T2 SI2247558 T2 SI 2247558T2
Authority
SI
Slovenia
Prior art keywords
imaging agents
neurological dysfunction
novel imaging
detecting neurological
detecting
Prior art date
Application number
SI200932157T
Other languages
English (en)
Other versions
SI2247558T1 (sl
Inventor
Hartmuth C. Kolb
Joseph C. Walsh
Qianwa Liang
Brian A. Duclos
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40627498&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2247558(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of SI2247558T1 publication Critical patent/SI2247558T1/sl
Publication of SI2247558T2 publication Critical patent/SI2247558T2/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SI200932157T 2008-02-14 2009-02-17 Nova kontrastna sredstva za zaznavanje nevroloških disfunkcij SI2247558T2 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6610108P 2008-02-14 2008-02-14
PCT/US2009/000961 WO2009102498A1 (en) 2008-02-14 2009-02-17 Novel imaging agents for detecting neurological dysfunction
EP09711194.2A EP2247558B2 (en) 2008-02-14 2009-02-17 Novel imaging agents for detecting neurological dysfunction

Publications (2)

Publication Number Publication Date
SI2247558T1 SI2247558T1 (sl) 2022-07-29
SI2247558T2 true SI2247558T2 (sl) 2024-10-30

Family

ID=40627498

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200932157T SI2247558T2 (sl) 2008-02-14 2009-02-17 Nova kontrastna sredstva za zaznavanje nevroloških disfunkcij

Country Status (16)

Country Link
US (2) US8318132B2 (sl)
EP (2) EP2599763A1 (sl)
JP (1) JP2011512354A (sl)
KR (1) KR20100135235A (sl)
CA (1) CA2715390A1 (sl)
CY (1) CY1125258T1 (sl)
DK (1) DK2247558T4 (sl)
ES (1) ES2907992T3 (sl)
FI (1) FI2247558T4 (sl)
HR (1) HRP20220401T4 (sl)
HU (1) HUE058352T2 (sl)
LT (1) LT2247558T (sl)
PL (1) PL2247558T5 (sl)
PT (1) PT2247558T (sl)
SI (1) SI2247558T2 (sl)
WO (1) WO2009102498A1 (sl)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8932557B2 (en) 2008-02-14 2015-01-13 Eli Lilly And Company Imaging agents for detecting neurological dysfunction
SI2247558T2 (sl) 2008-02-14 2024-10-30 Eli Lilly And Company Nova kontrastna sredstva za zaznavanje nevroloških disfunkcij
CA2733499A1 (en) * 2008-08-08 2010-02-11 Neurosearch A/S Novel diphenyl 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors
MX349711B (es) * 2008-09-18 2017-08-09 Cedars Sinai Medical Center Método óptico para la detección de la enfermedad de alzheimer.
US8691187B2 (en) * 2009-03-23 2014-04-08 Eli Lilly And Company Imaging agents for detecting neurological disorders
GB201016038D0 (en) 2010-09-24 2010-11-10 Ge Healthcare Ltd In vivo imaging method
SG10201508766UA (en) * 2010-10-29 2015-11-27 Clino Ltd Tau imaging probe
CA2844511A1 (en) * 2011-08-11 2013-02-14 Neuprotect Pty Ltd Flavonoid compounds, and methods of use thereof
US20130315825A1 (en) * 2012-05-03 2013-11-28 Washington University Tricyclic heteroaromatic compounds as alpha-synuclein ligands
EP2852572B1 (en) * 2012-05-22 2020-04-01 Eli Lilly and Company Carboline and carbazole based imaging agents for detecting neurological dysfunction
EP2767532B1 (en) 2012-12-21 2016-07-13 National Institutes for Quantum and Radiological Science and Technology Novel compound for imaging tau protein accumulated in the brain
US20160115162A1 (en) 2013-05-31 2016-04-28 The General Hospital Corporation Radiosynthesis of Tau Radiopharmaceuticals
UY35625A (es) 2013-06-25 2014-12-31 Bristol Myers Squibb Company Una Corporación Del Estado De Delaware Compuestos de tetrahidrocarbazol y carbazol carboxamida sustituidos como inhibidores de quinasa
JP6353530B2 (ja) 2013-06-25 2018-07-04 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ キナーゼ阻害剤として有用なカルバゾールカルボキサミド化合物
EA028483B1 (ru) * 2013-10-08 2017-11-30 Ф. Хоффманн-Ля Рош Аг ПРОИЗВОДНЫЕ ДИАЗОКАРБАЗОЛА В КАЧЕСТВЕ ПЭТ-ЛИГАНДОВ БЕЛКА tau
TWI667233B (zh) 2013-12-19 2019-08-01 德商拜耳製藥公司 新穎吲唑羧醯胺，其製備方法、含彼等之醫藥製劑及其製造醫藥之用途
WO2015110263A1 (en) * 2014-01-21 2015-07-30 Ac Immune Sa Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyolid-like proteins
KR102530129B1 (ko) 2014-05-13 2023-05-10 에프. 호프만-라 로슈 아게 중수소화된 헤테로사이클릭 화합물 및 이의 조영제로서의 용도
JP6782227B2 (ja) * 2014-09-05 2020-11-11 ザ・ジョンズ・ホプキンス・ユニバーシティー ＣａＭＫＩＩ阻害剤及びその使用
WO2016037131A1 (en) 2014-09-05 2016-03-10 Symbiomix Therapeutics, Llc Secnidazole for use in the treatment of bacterial vaginosis
RS59707B1 (sr) 2014-10-24 2020-01-31 Bristol Myers Squibb Co Derivati karbazola
UY36371A (es) 2014-10-24 2016-04-29 Bristol Myers Squibb Company Una Corporación Del Estado De Delaware Compuestos de indolcarboxamida inhibidores de quinasas tipo btk y tipo tec
CN107108555B (zh) 2014-10-24 2020-12-01 百时美施贵宝公司 三环阻转异构体化合物
MY191590A (en) * 2015-02-02 2022-06-30 Ucb Biopharma Sprl 9h-pyrrolo-dipyridine derivatives
CN105566269B (zh) * 2015-03-27 2018-07-10 北京大学 香豆素衍生物的制备、药理作用及治疗瘙痒的应用
CN105524034B (zh) * 2015-03-27 2018-08-17 北京大学 香豆素衍生物的制备、药理作用及治疗脑缺血的应用
WO2016196653A1 (en) 2015-06-01 2016-12-08 Symbiomix Therapeutics, Llc Novel nitroimidazole formulations and uses thereof
WO2017009454A1 (en) 2015-07-15 2017-01-19 Ac Immune S.A. Novel imaging compounds
EP3118202A1 (en) 2015-07-15 2017-01-18 AC Immune S.A. Dihydropyridopyrrole derivatives as tau-pet-ligands
DK3374358T3 (da) 2015-11-13 2021-03-08 Lilly Co Eli Azetidin-derivater til tau-billeddannelse
AU2017216212B2 (en) * 2016-02-03 2020-12-24 Janssen Pharmaceutica Nv Tau PET imaging ligands
SG11201811311VA (en) * 2016-07-22 2019-01-30 Ac Immune Sa Compounds for imaging tau protein aggregates
JP7059270B2 (ja) 2016-07-22 2022-04-25 エーシー・イミューン・エス・アー タウタンパク質凝集体を画像化するための化合物
WO2018024642A1 (en) 2016-08-02 2018-02-08 Ucb Biopharma Sprl 9h-pyrrolo-dipyridine derivatives
WO2018024643A1 (en) 2016-08-02 2018-02-08 Ucb Biopharma Sprl 9h-pyrrolo-dipyridine derivatives
EP3510031B1 (en) 2016-09-09 2020-12-02 H. Hoffnabb-La Roche Ag Process for preparation of 2-(6-nitropyridin-3-yl)-9h-dipyrido[2,3-b;3',4'-d]pyrrole
TW201906818A (zh) * 2017-05-31 2019-02-16 美商５１１製藥公司 新穎氘取代之正子發射斷層掃描（ｐｅｔ）顯影劑及其藥理應用
EP3743423A1 (en) 2018-01-24 2020-12-02 AC Immune SA Gamma-carboline compounds for the detection of tau aggregates
EP3743426A1 (en) 2018-01-24 2020-12-02 AC Immune SA Azacarboline compounds for the detection of tau aggregates
WO2019168170A1 (ja) * 2018-03-02 2019-09-06 国立大学法人 長崎大学 クロモン誘導体及びアミロイド関連疾患診断用組成物
EP3790883A4 (en) 2018-05-09 2022-08-24 Aprinoia Therapeutics Limited HETEROARYL COMPOUNDS AND USES THEREOF
EP4058065A4 (en) 2019-11-13 2023-05-03 Aprinoia Therapeutics Limited COMPOUNDS FOR DEGRADING TAU PROTEIN AGGREGATES AND THEIR USES
WO2023034339A1 (en) * 2021-08-30 2023-03-09 Pretzel Therapeutics, Inc. Hydroxy and alkoxy coumarins as modulators of polrmt
WO2023034346A1 (en) * 2021-08-30 2023-03-09 Pretzel Therapeutics, Inc. Chromen-2-one modulators of polrmt
US11938127B2 (en) 2021-09-28 2024-03-26 Wayne State University Methods and compositions relating to steroid hormone receptor-dependent proliferative disorders
TW202334089A (zh) 2021-11-02 2023-09-01 美商夫雷爾醫療公司 Ｐｐａｒｇ反向激動劑及其用途
WO2023204967A1 (en) * 2022-04-21 2023-10-26 Virginia Commonwealth University Nlrp3 inflammasome inhibitors and compositions and uses thereof
WO2024163546A1 (en) 2023-02-02 2024-08-08 Eli Lilly And Company Novel compounds for tau imaging

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5871894A (en) * 1992-12-21 1994-07-19 Mallinckrodt Medical, Inc. Polyhydric phenol compounds
EP0724588B1 (en) * 1993-09-17 1999-11-10 Smithkline Beecham Corporation Drug binding protein
US6417178B1 (en) 1994-07-19 2002-07-09 University Of Pittsburgh Amyloid binding nitrogen-linked compounds for the antemortem diagnosis of alzheimer's disease, in vivo imaging and prevention of amyloid deposits
NZ322674A (en) * 1995-10-17 1999-08-30 Searle & Co Method of detecting cyclooxygenase-2
JPH09165378A (ja) * 1995-12-15 1997-06-24 Seitai Kinou Kenkyusho:Kk Ｎ１−［１８ｆ］フルオロベンジル複素環化合物およびそれらの製造法
ZA989365B (en) 1997-10-15 1999-04-15 Boehringer Mannheim Pharm Corp Preparation for treating alzheimer's disease
JP2001048786A (ja) 1999-08-05 2001-02-20 Yamanouchi Pharmaceut Co Ltd 三環式ヘテロアリール誘導体
US20020115717A1 (en) 2000-07-25 2002-08-22 Francine Gervais Amyloid targeting imaging agents and uses thereof
US6696039B2 (en) 2001-04-23 2004-02-24 Trustees Of The University Of Pennsylvania Amyloid plaque aggregation inhibitors and diagnostic imaging agents
ES2435070T3 (es) * 2001-08-27 2013-12-18 The Trustees Of The University Of Pennsylvania Derivados de estilbeno y su uso para unión y formación de imágenes de placas amiloides
US20040006092A1 (en) 2001-08-31 2004-01-08 Neurochem, Inc. Amidine derivatives for treating amyloidosis
EP1442039A1 (en) 2001-10-31 2004-08-04 Bayer HealthCare AG Pyrimido (4,5-b) indole derivatives
WO2003103598A2 (en) * 2002-06-07 2003-12-18 University Of North Carolina At Chapel Hill Amidine derivatives for treating amyloidosis
CA2503245A1 (en) * 2002-10-24 2004-05-06 Merck & Co., Inc. Alkyne derivatives as tracers for metabotropic glutamate receptor binding
WO2004043496A1 (de) * 2002-11-11 2004-05-27 Austria Wirtschaftsservice Gesellschaft M.B.H. Fluor-18-markierte fluorchinolone
GB0229686D0 (en) 2002-12-20 2003-01-29 Amersham Plc Solid-phase fluorination of benzothiazoles
WO2004058764A1 (en) 2002-12-27 2004-07-15 Bayer Healthcare Ag 4-phenyl-pyrimido [4,5-b] indole derivatives
MXPA05013977A (es) 2003-06-23 2006-03-09 Neurochem Int Ltd Metodos y composiciones para tratar enfermedades relacionadas con amiloide.
WO2005016888A1 (ja) 2003-08-13 2005-02-24 Bf Research Institute, Inc. アミロイド蓄積性疾患のプローブ、アミロイド染色剤、アミロイド蓄積性疾患の治療および予防薬、ならびに神経原線維変化の診断プローブおよび染色剤
JP2006100537A (ja) 2004-09-29 2006-04-13 Konica Minolta Holdings Inc 有機エレクトロルミネッセンス素子、照明装置及び表示装置
US20060110787A1 (en) * 2004-11-19 2006-05-25 The Board Trustees Of The University Of Arkansas Use of fluorine-18-labeled fluoroquinolone antibiotics for diagnosing and monitoring bacterial infection
EP1815872A4 (en) * 2004-11-26 2011-06-15 Univ Nagasaki COMPOSITION FOR THE DIAGNOSIS OF AMYLOID ASSOCIATED DISEASE
JP2007084526A (ja) * 2004-11-26 2007-04-05 Nagasaki Univ アミロイド関連疾患診断用組成物
ES2526655T3 (es) * 2004-12-17 2015-01-14 The Trustees Of The University Of Pennsylvania Derivados de estilbeno y su uso para la unión y la visualización de placas amiloides
FR2885905A1 (fr) 2005-05-23 2006-11-24 Trophos Sa Nouveaux composes chimiques et leurs utilisations comme medicament
WO2007002540A2 (en) * 2005-06-24 2007-01-04 Kung Hank F Radiolabeled-pegylation of ligands for use as imaging agents
CA2616397A1 (en) * 2005-08-03 2007-02-08 Centre For Addiction And Mental Health Diagnosis and treatment of mood disorders
GB0523506D0 (en) * 2005-11-18 2005-12-28 Hammersmith Imanet Ltd Novel in vivo imaging compounds
JP5249772B2 (ja) * 2005-11-22 2013-07-31 メルク・シャープ・アンド・ドーム・コーポレーション キナーゼの阻害剤として有用な三環式化合物
JP4738419B2 (ja) 2005-11-30 2011-08-03 富士フイルムＲｉファーマ株式会社 アミロイドの凝集及び／又は沈着に起因する疾患の診断薬及び治療薬
AR059356A1 (es) * 2006-02-14 2008-03-26 Astrazeneca Ab Nuevos radioligandos
JP2007223952A (ja) 2006-02-23 2007-09-06 Tohoku Univ アミロイドβ蛋白が蓄積する疾患の画像診断プローブ
WO2008118122A2 (en) * 2006-05-08 2008-10-02 Molecular Neuroimaging, Llc Compounds and amyloid probes thereof for therapeutic and imaging uses
US7678819B2 (en) 2006-12-07 2010-03-16 The Trustees Of The University Of Pennsylvania Acetylene derivatives and their use for binding and imaging amyloid plaques
ES2415863T3 (es) 2006-12-22 2013-07-29 Incyte Corporation Heterociclos sustituidos como inhibidores de Janus Quinasas
EP1944281A1 (en) 2007-01-09 2008-07-16 Technische Universität München 18F-labeled compounds, method for the preparation and use thereof
BRPI0702640A (pt) * 2007-01-10 2008-08-26 Comissao Nac Energia Nuclear processo de radiomarcação de flavonóides e sua aplicação em diagnóstico in vivo de disfunções cerebrais relacionadas aos sìtios receptores benzodiazepìnicos
EP2144916A4 (en) 2007-04-10 2012-01-04 Univ Pennsylvania PHENYLNAPHTHALENE DERIVATIVES AND PHENYLQUINOLINES AND THEIR USE FOR THE BINDING AND FORMATION OF AMYLOID PLATE IMAGES
JP2010524965A (ja) 2007-04-19 2010-07-22 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア ジフェニル−ヘテロアリール誘導体並びにアミロイド斑への結合及び画像化のためのその使用
WO2008132454A1 (en) * 2007-04-26 2008-11-06 Ge Healthcare Limited Carbolines and their use as imaging agents
US8942164B2 (en) 2007-10-22 2015-01-27 Texas Instruments Incorporated Differential CQI for OFDMA systems
CA2699965A1 (en) 2007-07-04 2009-01-08 Tohoku University Pet probe having an alkoxy group substituted by fluorine and hydroxy group
WO2009045535A2 (en) 2007-10-04 2009-04-09 Sloan-Kettering Institute For Cancer Research Fluorine-18 derivative of dasatinib and uses thereof
SI2247558T2 (sl) 2008-02-14 2024-10-30 Eli Lilly And Company Nova kontrastna sredstva za zaznavanje nevroloških disfunkcij
CA2731738A1 (en) 2008-07-24 2010-01-28 Siemens Medical Solutions Usa, Inc. Imaging agents useful for identifying ad pathology
JP2012051804A (ja) 2008-12-26 2012-03-15 Kyoto Univ Ｅｇ５阻害剤
EP2218464A1 (en) 2009-02-11 2010-08-18 Technische Universität München Compounds for non-invasive measurement of aggregates of amyloid peptides
EA028483B1 (ru) 2013-10-08 2017-11-30 Ф. Хоффманн-Ля Рош Аг ПРОИЗВОДНЫЕ ДИАЗОКАРБАЗОЛА В КАЧЕСТВЕ ПЭТ-ЛИГАНДОВ БЕЛКА tau
MY191590A (en) 2015-02-02 2022-06-30 Ucb Biopharma Sprl 9h-pyrrolo-dipyridine derivatives

Also Published As

Publication number Publication date
HRP20220401T3 (hr) 2022-05-27
ES2907992T3 (es) 2022-04-27
US20110091382A1 (en) 2011-04-21
SI2247558T1 (sl) 2022-07-29
US8318132B2 (en) 2012-11-27
CA2715390A1 (en) 2009-08-20
PL2247558T3 (pl) 2022-05-02
PL2247558T5 (pl) 2024-10-14
LT2247558T (lt) 2022-04-11
HRP20220401T4 (hr) 2024-09-27
FI2247558T4 (fi) 2024-09-19
JP2011512354A (ja) 2011-04-21
DK2247558T4 (da) 2024-07-29
EP2599763A1 (en) 2013-06-05
CY1125258T1 (el) 2024-02-16
EP2247558B2 (en) 2024-07-03
US20110046378A1 (en) 2011-02-24
EP2247558A1 (en) 2010-11-10
EP2247558B1 (en) 2022-02-02
DK2247558T3 (da) 2022-02-21
KR20100135235A (ko) 2010-12-24
WO2009102498A1 (en) 2009-08-20
HUE058352T2 (hu) 2022-07-28
PT2247558T (pt) 2022-03-21

Similar Documents

Publication Publication Date Title
HRP20220401T3 (hr) Nova vizualizacijska sredstva za detektiranje neurološke disfunkcije
HK1183021A1 (zh) 用於檢測神經障礙的成像劑
SG10201706428XA (en) Charge-balanced imaging agents
GB2458223B (en) Imaging device
PL2345175T3 (pl) Struktura sygnału referencyjnego dla systemu LTE-Advanced
EP2296368A4 (en) IMAGING DEVICE
GB0610395D0 (en) Novel imaging agents
IL212550A0 (en) Apj receptor compounds
EP2317923A4 (en) IMAGING WITH EXTENDED RANGE
EP2362779A4 (en) CXCR4 RECEPTOR COMPOUNDS
GB0712682D0 (en) Phantom for imaging apparatuses
GB2448479B (en) Improved shim for imaging magnets
EP2336821A4 (en) IMAGING DEVICE
GB0808878D0 (en) Seismic imaging
EP2288139A4 (en) IMAGING DEVICE
EP2352277A4 (en) IMAGING DEVICE
GB0818738D0 (en) Imaging neuroflammation
TWI372310B (en) Imaging device
GB0818151D0 (en) Imaging techniques
EP2312828A4 (en) IMAGING DEVICE
HK1200823A1 (en) N-alkoxyamide conjugates as imaging agents n-
EP2271372A4 (en) IMAGING AGENT
GB0722650D0 (en) Novel imaging method
GB0817044D0 (en) Imaging agents
GB0821433D0 (en) Imaging Agents